Nicotinamide riboside

未知生产厂商

Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and Mitochondrial Biogenesis).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and Mitochondrial Biogenesis).

技术标识符

化学式: C₁₁H₁₅N₂O₅
CAS 编号: 1341-23-7
UNII ID: 0I8H2M0L7N

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

NICOTINOYL RIBOSIDE AND NICOTINAMIDE RIBOSIDE COMPOSITIONS FOR USE IN REDUCING TOXICITY INDUCED BY HMG-COA REDUCTASE INHIBITORS
EP 3730507 A1申请人: CORNELL RES FOUNDATION INC优先权: 2005
EP
US
11 件公开
SUBSTANCES FOR TREATMENT OF FATTY LIVER-RELATED CONDITIONS
EP 3808347 B1申请人: SCANDIBIO THERAPEUTICS AB优先权: 2016
CN
EP
US
WO
9 件公开
LEUCINE AND NICOTINIC ACID FOR THE REDUCTION OF LIPID LEVELS
EP 2968333 B1申请人: NUSIRT SCIENCES INC优先权: 2013
EP
US
WO
9 件公开
NICOTINAMIDE RIBOSIDE AND DERIVATIVES THEREOF IN INTRAVENOUS FORMULATIONS AND METHODS OF USE THEREOF
EP 4727544 A2申请人: CHROMADEX INC优先权: 2023
CN
EP
US
WO
6 件公开
COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS
EP 3820433 A1申请人: NUCHIDO LTD优先权: 2018
CN
EP
US
WO
5 件公开
METHODS AND COMPOSITIONS FOR TREATING MOTOR NEURON DISEASES
EP 3930728 A1申请人: UNIV DE VALENCIA ESTUDI GENERAL优先权: 2019
CN
EP
US
WO
5 件公开
COMPOSITIONS AND METHODS FOR INCREASING T CELL FUNCTION
EP 3946306 A2申请人: NESTLE SA优先权: 2019
CN
EP
US
WO
5 件公开
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
US 10857172 B2申请人: CHROMADEX INC优先权: 2016
CN
US
5 件公开
Nicotinamide riboside kinase compositions and methods for using the same
- US 8197807 B2
  申请人: BRENNER CHARLES M优先权: 2006
  US
  5 件公开
- US 2005227327 A1
  申请人: BRENNER CHARLES M优先权: 2005
  US
Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations
US 12485134 B2申请人: CHROMADEX INC优先权: 2019
CN
US
WO
4 件公开

药物

Nicotinamide riboside

概览

专利

Nicotinamide riboside kinase compositions and methods for using the same